Zheng Quan Shi Bao Wang·2025-10-15 09:16Group 1 - The CRO concept index rose by 2.56%, ranking 10th among concept sectors, with 64 stocks increasing in value, led by Hanyu Pharmaceutical, Boteng Co., and Meidi Xi, which rose by 7.87%, 6.85%, and 6.28% respectively [1][2] - The top three stocks in terms of net inflow of main funds were Hanyu Pharmaceutical with a net inflow of 172 million yuan, followed by Fosun Pharma and Huace Testing with net inflows of 40.96 million yuan and 36.48 million yuan respectively [2][3] Group 2 - The main fund inflow rates for stocks such as Ruizhi Pharmaceutical, Hanyu Pharmaceutical, and Jiannang Technology were 10.21%, 10.19%, and 8.41% respectively, indicating strong investor interest [3] - The CRO concept sector saw a net inflow of 322 million yuan today, with 45 stocks experiencing net inflows, and five stocks exceeding 30 million yuan in net inflow [2][3] Group 3 - The stocks with the highest trading turnover in the CRO concept included Hanyu Pharmaceutical with a turnover rate of 10.59%, followed by Fosun Pharma at 0.88% and Huace Testing at 5.74% [3][4] - The overall performance of the CRO concept was positive, with several stocks showing significant gains, while a few, such as Inno Laser and ST Weiming, experienced declines of 3.16% and 1.74% respectively [1][5]